Background Biliary tract cancers, which arise from the intrahepatic or extrahepatic bile ducts
and the gallbladder, generally have a poor prognosis and are rising in incidence worldwide. …

Background Patients with advanced or metastatic oesophageal squamous cell carcinoma
have poor prognosis and few treatment options after first-line therapy. We aimed to assess …

Objective To evaluate sintilimab versus placebo in combination with chemotherapy (cisplatin
plus paclitaxel or cisplatin plus 5-fluorouracil) as first line treatment of unresectable locally …

Background Immunotherapy combined with chemotherapy has been shown to be efficacious
as treatment for advanced non-squamous non-small-cell lung cancer (NSCLC) without …

Importance Programmed cell death ligand 1 inhibitors combined with chemotherapy has
changed the approach to first-line treatment in patients with extensive-stage small cell lung …

Background VEGF inhibitors can enhance the efficacy of immunotherapy. However, despite
high initial response rates, almost all patients eventually develop treatment resistance to …

This article reports on a noninvasive approach in detecting and following-up individuals
who are at-risk or have an existing COVID-19 infection, with a potential ability to serve as an …

Introduction Camrelizumab, a humanized immunoglobulin G4-κ monoclonal antibody against
programmed cell death protein 1, has exhibited antitumor activity and tolerability across …

Background Apatinib is a tyrosine kinase inhibitor targeting vascular endothelial growth
factor receptor 2(VEGFR-2). This study was conducted to assess the efficacy and safety of …

Background Tucidinostat (formerly known as chidamide) is an oral subtype-selective
histone deacetylase inhibitor. In an exploratory study, the combination of tucidinostat with …